Green L W, Mullen P D, Friedman R B
Patient Educ Couns. 1986 Sep;8(3):255-68. doi: 10.1016/0738-3991(86)90004-2.
Reliance on pharmaceuticals for medial therapy, especially for chronic conditions in an aging society, poses important questions regarding patient's understanding of and adherence to their drug regimens. Related policy issues have been debated chiefly in the context of regulations administered by the Food and Drug Administration (FDA), such as the once proposed 'patient package inserts'. A population-based analysis of the distribution of health risks and drug utilization errors--including errors of omission--identifies a set of allocation issues for improving use of medications for public health as well as medical and pharmacy practice. These issues center particularly on channels and targets of drug information, including mass media, community and private medical practices, age and sex groupings within the patient and non-patient populations, and selected diseases, conditions and drugs requiring more attention. A conceptual framework for determining information needs is developed with recommendations for a combined public health and patient education strategy for the reduction of drug errors and the enhancement of drug benefits.
依赖药物进行医学治疗，尤其是在老龄化社会中治疗慢性病，引发了有关患者对其药物治疗方案的理解和依从性的重要问题。相关政策问题主要是在食品药品监督管理局（FDA）实施的监管背景下进行辩论的，比如曾经提议的“患者用药指南”。一项基于人群的健康风险分布和药物使用错误（包括漏服错误）分析，确定了一系列分配问题，以改善药物在公共卫生以及医疗和药学实践中的使用。这些问题尤其集中在药物信息的传播渠道和目标人群上，包括大众媒体、社区和私人医疗实践、患者和非患者人群中的年龄和性别分组，以及某些需要更多关注的疾病、病症和药物。为确定信息需求制定了一个概念框架，并提出了关于公共卫生和患者教育相结合策略的建议，以减少用药错误并提高药物疗效。
